<b style="">Pharmaceutical development of novel microalgal compounds for Mdr <i style="">Mycobacterium</i> <i style="">tuberculosis</i></b>

Abstract

264-269The role of marine algae in the discovery of drugs that could reach the pharmaceutical market has increased notably in recent years, due to a substantial improvement in biological screening methods. Multi Drug Resistant (MDR) TB is the major hurdle in the TB control programmes. The selected resistant strains of Mycobacterium tuberculosis were screened for the bioactive compounds extracted from marine microalgae. It is noted that Isochrysis galbana has rich bioactive compounds than the other algal species